Tick Bites, Vaccines, and the Meat Allergy Epidemic

By Peter A. McCullough, MD, MPHMore and more Americans are developing alpha-gal syndrome after a tick bite.  Steve Gruber asked Dr. McCullough on DayBreak about this emerging meat allergy and what is behind the epidemic.🎙 Dr. Peter McCullough on Alpha-Gal Syndrome — Steve Gruber Show SummaryThe InterviewDr. Peter McCullough, Chief Scientific Officer at The Wellness Company, joined Steve Gruber onReal America’s Voiceto discuss a new study from the McCullough Foundation and Wellness Company team examining risk factors behind the dramatic rise ofalpha-gal syndrome (AGS)— an acquired meat allergy that can produce delayed anaphylaxis, urticaria, and angioedema hours after eating mammalian products.🔬 The Hulscher et al. PaperMcCullough referenced the newly released paper:Nicolas Hulscher, MPH, James A. Thorp, MD, Drew Pinsky, MD, Peter Gillooly, MSc, Harvey Risch, MD, PhD, Peter A. McCullough, MD, MPH, & Kelly Victory, MD. (2026).Risk Factors, Pathogenesis, and Management of Alpha-Gal Syndrome.Zenodo.https://doi.org/10.5281/zenodo.22003548The paper advances two non-exclusive hypotheses about how vaccine-derived alpha-gal — present in mammalian gelatin used as a stabilizer — could contribute to AGS:Direct induction: Repeated parenteral exposure to alpha-gal-bearing gelatin with aluminum adjuvant directly drives IgE class switchingPrime-boost: Gelatin-containing vaccines expand the alpha-gal-specific memory B-cell pool, after which a tick bite delivers a potent adjuvant signal that boosts the response to clinically relevant IgE titersMcCullough emphasized that the average tick bite victim is about 35 years old, has taken many childhood vaccines like most Americans, and then gets a tick bite that triggers the allergy. The paper notes that alpha-gal IgE is now detectable in24% of adultsin high-burden states, with suspected cases rising roughly 100-fold over the past decade.💊 Two TWC Products MentionedHistacalm— A botanical combination (quercetin, luteolin, apigenin, pine bark extract, and butterbur) that stabilizes mast cells and basophils from releasing histamine. McCullough described it as calming the allergic response so that meat can be gradually reintroduced — a desensitization approach — allowing patients to “go on with their lives after this tick bite.” The paper details how these five constituents target distinct nodes of the effector cascade: degranulation, Th2 cytokine production, leukotriene synthesis, H1 signaling, and oxidative amplification.Bug Defense— A safe botanical insect repellent. McCullough’s practical advice was straightforward: “No tick bite, no alpha-gal syndrome.” He recommended wearing long sleeves and pants in the woods (particularly applicable to Gruber’s Michigan audience) and using Bug Defense as a preventative. The ticks don’t like it, and prevention remains the single most impactful measure available.🦠 Broader ContextMcCullough and Gruber also touched on:Vaccine hesitancybeing driven by Anthony Fauci’s legacy, not by voices like RFK Jr. or McCullough — with the rate of unvaccinated children rising from ~2.5% several years ago to ~4.2%Gain-of-function researchon ticks and mosquitoes, with McCullough calling for the entire industry to be shut down, noting the line of thinking that Lyme disease may have originated from a research lab in Lyme, ConnecticutTheconflict of interestinherent in government-funded vaccine research, given the government’s co-ownership of the Moderna patentThe need forindependent researchthrough organizations like the McCullough Foundation and Wellness Company, free from the constraints of government RFAs and industry biasFOCAL POINTS (Courageous Discourse™) is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.📝Please subscribe toFOCAL POINTSas a paying ($5 monthly) or founder member so we can continue to bring you the truth.AlterAImay be used to assist in searches, synthesis, and review.Peter A. McCullough, MD, MPHChief Scientific Officer, The Wellness Companywww.twc.health/focalpoints

Summary: McCullough Foundation & The Wellness Company paper proposes two-pronged pathogenesis of alpha-gal syndrome, while TWC's Bug Defense and Histacalm offer practical solutions for prevention and recovery


How the Vaccine Cartel Is Making False Claims about Shingles Vaccination Reducing Heart and Neurodegenerative Disease

By Peter A. McCullough, MD, MPHWhen I took the shingles vaccine several years ago, my arm blew up like a red balloon and I had pain and fever—that is inflammation big-time.  It has been learned that both cardiovascular and neurodegenerative diseases have deterministic elements of chronic inflammation.  In other words, inflammation is not good for the heart or the brain—and that includes systemic inflammation from vaccines.🧠 The “Shingles Vaccine Miracle:” When Observational Studies Become MarketingTwo new studies published inNature Medicineand theAnnals of Internal Medicineare making headlines with a seductive claim: the recombinant shingles vaccine may slash your risk of heart disease and dementia. TheCorsi-Zuelli paperreports a 9% reduction in cardiovascular events. TheHayes paper, published inAnnals, claims a 25% reduction in dementia risk.  From an epidemiological perspective these are tiny effect sizes.It’s a beautiful story. Get your jab, protect your heart, save your brain. Who wouldn’t want that?The problem is that the story is almost certainly false. And the reasons it’s false reveal everything wrong with how the vaccine establishment manufactures evidence when it needs to move product.Read more

Summary: Non-randomized, healthy-vaccinee bias, unadjudicated billing codes, effect sizes too tiny to outrun random variation, conflicts of interest buried in fine print — the shoddy science of vaccinology


Chasing SARS-CoV-2 Mutational Strains: Why the Fall Booster Program Is Always a Variant Behind

By Peter A. McCullough, MD, MPHIts fall and another season of wasted government money on unpopular and rarely taken COVID-19 boosters.  The 2026–2027 boosters from Pfizer/BioNTech, Moderna, and Novavax/Sanofiall target the XFG variant— and by the time they hit pharmacy shelves this week, the variant landscape has already moved. That’s not a coincidence of timing. It’s the structural reality of chasing a nonseasonal virus that mutates faster than the regulatory approval pipeline can move.  The theoretical vaccine efficacy only lasts a few months.🎯 What the Boosters Actually CoverAll three manufacturers’ 2026–2027 formulations are built around a single antigen target:Pfizer/BioNTech (COMIRNATY® XFG)— mRNA, targetsXFGModerna (Spikevax and mNexspike)— mRNA, targetsXFG, a subvariant of the JN.1 lineageNovavax (Nuvaxovid™, sold via Sanofi)— protein-based, targetsXFGThat’s it. One strain, three products. The FDA selected XFG back inMay 2026based on what was circulating in the spring. The manufacturers’ own press materials claim the shots generate responses against other lineages — XFG.1.1, NB.1.8.1, PQ.17, PQ.2.8.1 — but the antigen itself is XFG, and the “broadening” is theoretical cross-reactivity, not a designed match.Subscribe nowRead more

Summary: The Virus Mutates and Infects Year-Round — But the FDA Is Still Stuck on a Poorly-Conceived Flu-Season Playbook


MMR Vaccine-Linked Deaths Outnumber Measles Deaths in 2026

byNicolas Hulscher, MPHSo far in 2026, there have beenZERO confirmed measles deathsand at leastTHREE MMR vaccine-linked deathsin the United States.Yet Americans hear virtually nothing about deaths occurring after MMR vaccination. Instead, the captured mass media blasted out headlines claiming that two children in Pennsylvania had died from measles—claims that have since fallen apart under scrutiny. Meanwhile, three highly concerning MMR-linked deaths have already appeared in VAERS this year:2026 U.S. MMR VACCINE DEATH REPORTS (VAERS): 31-year-old boy: fatal cardiac arrest just ONE DAY after MMRThefirst caseinvolves a1-year-old boy who suffered fatal cardiac arrest just one day after receiving MMR. The extraordinarily short interval makes the report impossible to simply dismiss as some distant event occurring long after vaccination. Along with MMR, he was also subjected to a battery of four additional vaccines—Varivax, Havrix, Vaxelis, and Prevnar 20—for five vaccines total at the same visit. The child was hyper-vaccinated and died the following day.1-year-old girl: died from disseminated rubella after MMRThesecond caseis even more biologically concerning. A1-year-old girl died from disseminated rubella after receiving MMR. She reportedly had an undiagnosed primary immunodeficiency when she was vaccinated.This matters because MMR does not contain an inert rubella antigen. It contains a live attenuated rubella virus designed to replicate in a controlled manner and generate immunity. In a person with severe immune dysfunction, however, the immune system can fail to adequately contain or eliminate the attenuated virus. Instead of remaining limited, vaccine-strain virus can persist and disseminate into tissues throughout the body leading to multi-organ failure.76-year-old woman: vaccine-strain measles detected during fatal pneumoniaThethird casemay be the most remarkable of all. A76-year-old woman developed measles vaccine-associated pneumonia after receiving MMR, progressed to severe respiratory failure, and died after a 16-day hospitalization.Critically,vaccine-strain measles was detected in her respiratory tract, including pulmonary samples. In other words, this was not simply a patient who happened to test positive for measles after vaccination. Molecular testing identified the vaccine strain itself.The measles component of MMR is also a live attenuated virus. In immunocompromised individuals, the weakened virus can escape normal immune control, continue replicating, and produce serious systemic disease. When that process involves the lungs, it can produce measles pneumonitis or pneumonia, impair oxygen exchange, and progress to respiratory failure.2026 U.S. MEASLES DEATHS: 0Now contrast those three reports withwhat happened in Pennsylvania.Pennsylvania officials announced two “measles-associated deaths,” but theCDC refused to add them to the national measles death count, stating that the available information “does not establish whether measles caused or contributed to the deaths or whether the individuals died from other causes while infected with measles.”The first infant did not die from measles according to the coroner’s assessment of the primary cause of death. The child suffered a ruptured or lacerated spleen with catastrophic internal bleeding. Despite that, the death was publicly promoted as “measles-associated.”The second Pennsylvania case remains even less clear. No case details have been released, no cause of death has been provided, and there has been no confirmation of measles involvement. It may be an entirely fabricated “measles death” pending the release of such information.CONCLUSIONThat leaves an extraordinary contrast in 2026:ZERO confirmed U.S. measles deaths, while at leastTHREE deaths have already been reported following MMR vaccination.One involved fatal cardiac arrest the day after vaccination.One involved fatal disseminated rubella after administration of a live rubella-containing vaccine.And one involved fatal measles vaccine-associated pneumonia with vaccine-strain measles detected in the respiratory tract.VAERS is widely recognized to besubstantially underreported. A federally funded investigation led byLazarus et al.found that fewer than 1% of vaccine adverse events may be reported to national surveillance systems. In other words, there are likely far more 2026 MMR vaccine deaths.These three 2026 reports also arrive against the backdrop of ourrecent nationwide study of MMR/MMRV-associated mortalityin VAERS, where we found hundreds of sudden deaths among infants and toddlers within days of MMR vaccination—2,657% more deaths than measles itself. The fatal presentations included sudden infant death syndrome and unexplained sudden death, cardiac arrest, seizures, respiratory distress, encephalitis, and severe febrile illness.The captured mass media will blast an alleged measles death across the country before the underlying facts are even known. But when a toddler dies one day after MMR, or when vaccine-strain virus itself is implicated in a fatal illness, the silence is deafening.Nicolas Hulscher, MPHEpidemiologist and Foundation Administrator, McCullough FoundationSupport our mission:mcculloughfnd.orgPlease consider following both theMcCullough Foundationandmy personal accountonX(formerly Twitter) for further content.FOCAL POINTS (Courageous Discourse™) is a reader-supported publication. To receive new posts and support my work, consider becoming a paid subscriber.

Summary: A 1-year-old died from cardiac arrest one day after MMR, another 1-year-old died from disseminated vaccine rubella, and a 76-year-old died from vaccine-associated measles pneumonia.


EnteroMix: Promise and Peril in Russia’s Personalized Cancer Vaccine

By Peter A. McCullough, MD, MPHThe news was buzzing about a Russian cancer vaccine back in 2024-25.  But the story has gone cold in 2026; I wondered why?🔬 How It WorksEnteroMix is a Russian-developed therapeutic cancer vaccine combining two strategies. The first is anoncolytic viral cocktail— four replication-competent enteroviruses (CVA21, ECHO-7, EV-B75, and a poliovirus–rhinovirus chimera) that selectively infect and lyse tumor cells, releasing antigens and danger signals that “heat” the tumor microenvironment. The second is apersonalized mRNA vaccine— synthesized from the patient’s own tumor RNA — that encodes patient-specific neoantigens, training T-cells to hunt cancer cells bearing those mutational signatures.Subscribe nowRead more

Summary: A Cautious Examination of the Dual-Platform Immunotherapy